Fighting a Moving Target: SARS-CoV-2 Variants and Viral Escape

preview_player
Показать описание
Presenter: Jonathan Li, MD, MMsc
Date: March 16, 2021
  1. IAS-USA
Рекомендации по теме
Fighting a Moving 1:28:05

Fighting a Moving Target: SARS-CoV-2 Variants and Viral Escape

UPDATE 4/22/2020 - 0:22:47

UPDATE 4/22/2020 - COVID-19: Keeping Up with a Moving Target

UPDATE 4/1/2020 - 0:21:10

UPDATE 4/1/2020 - COVID-19: Keeping Up with a Moving Target

Omicron a moving 0:03:12

Omicron a moving target in the war against Covid

Identifying potential drug 0:01:00

Identifying potential drug targets for fighting SARS-CoV-2

Oral Therapies for 0:30:50

Oral Therapies for SARS-CoV-2: Evidence-Based Health Information Related to COVID-19

Efforts by the 0:37:53

Efforts by the OTS community to combat SARS-CoV-2 and COVID-19

Racing against COVID-19: 1:33:43

Racing against COVID-19: Drug and Vaccine Development

Tracing Coronavirus Variants 0:09:14

Tracing Coronavirus Variants | What to Know | WTK

SARS-CoV-2 Variants and 0:20:26

SARS-CoV-2 Variants and Their Potential Biological Implications | Vineet Menachery, PhD

SARS-CoV-2 Variants and 1:01:08

SARS-CoV-2 Variants and the Safety of COVID-19 Vaccines in the U.S.

February 28, 2021 0:58:56

February 28, 2021 ACIP Meeting - GRADE: Janssen COVID-19 vaccine

Coronavirus Mutations and 0:39:47

Coronavirus Mutations and COVID 19 Vaccine Implications with Shane Crotty, PhD (SARS CoV 2 Variants)

GenScript's Response to 0:44:13

GenScript's Response to the SARS-CoV-2 Pandemic: Innovations in Diagnostic Solutions with Live ...

Neurological Associations of 1:00:44

Neurological Associations of COVID-19: Olfactory transmucosal invasion and psychosis risk

11/2/2021 - Breaking 0:52:01

11/2/2021 - Breaking Barriers to COVID-19 Equity

How can your 0:06:21

How can your practice improve access to anti-SARS-CoV-2 monoclonal antibodies?

In-depth: Will variants 0:03:05

In-depth: Will variants escape COVID-19 vaccines?

FIND webinar series: 1:12:18

FIND webinar series: insights on Feluda (CRISPR based SARS-CoV-2 test)

All Round Efforts 1:11:33

All Round Efforts to Fight COVID 19 Pandemic

COVID-19 and Other 0:50:02

COVID-19 and Other Dangerous New Viral Diseases: Where do they come from? How can we fight them?

SARS-COV-2 Variants, Vaccines, 1:31:06

SARS-COV-2 Variants, Vaccines, Breakthrough Infections, Microbiomes in Motion

Novavax COVID-19 vaccine 0:21:46

Novavax COVID-19 vaccine efficacy against SARS-CoV-2 and variants (#51)

Common Cold T-Cells 0:06:29

Common Cold T-Cells Can Fight Covid: ICL Study

visit shbcf.ru